| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_378bcede5d4b50e4947470a09429b5fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7db4d26f1350fbe171794d620c228f18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc52f75a6a6b8334fc614a594b23fdf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f96b5bb7ce368428f9404a52077b33dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83e76b97734201cb045eadf9a59490c0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2008-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70968254d64696dd22822d1cd05ba2a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d11bcb0817e69c0c8fb6e61fc4a6691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec367fb19872927292a73621bcfe45e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a86c5c529300b5bd5fc65896c7222482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3e2825f056d4848a65379a77c404784 |
| publicationDate |
2009-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009093395-A1 |
| titleOfInvention |
Method for determining predisposition to pulmonary infection |
| abstract |
Provided herein are methods and materials for diagnosing a subject's predisposition for pulmonary infection in a CF subject by detecting a pulmonary infection genetic marker. Pulmonary infection markers have been identified in the IL-1 gene cluster and may be useful in predicting CF disease progression and assessing a CF subject's response to therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015224202-A1 |
| priorityDate |
2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |